Line Marking

The FDA continues to exert regulatory pressure on OEM’s and Contract Manufactures which supply complete medical implant products or components. A common area of scrutiny is the requirement to maintain material traceability for the life of the device. Material traceability (and other critical supply chain and process information) is recorded and maintained in a document package named the Device History …